13.07.2015 Views

Dressings and Topical Agents for Chronic Wounds - NIHR Health ...

Dressings and Topical Agents for Chronic Wounds - NIHR Health ...

Dressings and Topical Agents for Chronic Wounds - NIHR Health ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Health</strong> Technology Assessment 1999; Vol. 3: No. 17 (Pt 2)both of which are oxygen free radical scavengers<strong>and</strong> were evaluated in the same trial. This trialneeds to be replicated as the possibility that thecomparator (an inert powder) may have had adetrimental effect on healing cannot be ruled out.DMSO has also been found to be effective in thetreatment of diabetic foot ulcers <strong>and</strong> is worthy offurther investigation. 139Biologically active topical agents, cells ormembranes, were not found to be more effectivethan control dressings, such as paraffin gauze orculture medium. Similarly, growth factors were notdemonstrated to be more effective than the tissueculture medium alone. This is in contrast withevaluations in the treatment of diabetic foot ulcerswhere they have been shown to be effective. 139There may be two explanations <strong>for</strong> this.• There may be differences in microcirculatorypathology between diabetic <strong>and</strong> venous ulcers;the <strong>for</strong>mer being amenable to treatment bygrowth factor.• Growth factors are effective in the treatment ofvenous leg ulcers but the method of application<strong>and</strong>/or the power of the studies has resultedin a type 2 error. One striking difference in theapplication of growth factors to the two differentwound types is the amount of debridementper<strong>for</strong>med. During the treatment of diabeticfoot ulcers, the skin <strong>and</strong> wound are frequentlydebrided to remove dead tissue. 139 A bleedingwound bed may be prepared prior to the applicationof the growth factors. Sharp debridementis rarely per<strong>for</strong>med on venous leg ulcers <strong>and</strong>there was no pretreatment debridement in thetrials reported here. 127–130Comparisons between dressings <strong>and</strong> topical agentsindicated that a collagen dressing was preferableto the daily application of an antiseptic, while ahydrocolloid dressing healed more ulcers thanmagnesium paste. However, neither magnesiumpaste nor topical antiseptic are widely used todayin the UK suggesting that the generalisability ofthese results is limited.Publication biasFunnel plots indicated that publication bias may bepresent <strong>for</strong> trials that compared hydrocolloids withtraditional treatments. Asymmetry of the funnelplot can result from: 140• publication bias• language bias• multiple publication bias• poor methodological design amongstsmaller studies• true heterogeneity (i.e. ES differs accordingto study size due to intensity of intervention)• chance.It is inevitable that despite searching <strong>for</strong>unpublished studies this review relies heavilyon published trials. There is at present nost<strong>and</strong>ardised method to ensure a comprehensivesearch <strong>for</strong> unpublished data. Careful screeningof all included studies was undertaken to reducethe potential <strong>for</strong> multiple studies <strong>and</strong> the searchstrategy was designed to improve sensitivity <strong>for</strong>non-English publications. True heterogeneity isunlikely to have influenced publication bias asthe largest studies did not employ interventionsthat differed from the smaller ones. The almostuni<strong>for</strong>m direction of the bias suggests that itwas not purely a chance result. Poor methodologicaldesign of the smaller studies could beresponsible <strong>for</strong> skewing the funnel plot; thesmaller effect size demonstrated in the larger,more rigorous studies may indicate this.However, publication bias remains the mostlikely cause of asymmetry. 140 This type of biasmay result from restrictive practices that preventall the evaluative research entering the publicdomain. There are several reasons why publicationbias could skew the data, two of the mostcommon causes are:• pharmaceutical companies are unlikely tofavour the publication of sponsored trialswhere a result favoured the st<strong>and</strong>ard, genericalternative. Such suppression of publicationis more likely <strong>for</strong> small, under-poweredstudies than <strong>for</strong> large, multicentre trials• journal editors or researchers may notfavour publication of small studies with‘null’ (i.e. non-significant) results, particularlyif they have been preceded by largerstudies that indicated a positive benefit <strong>for</strong>an intervention. This does not appear tobe the case here as the majority of trialswere non-significant.Analysis of the funnel plot by date of publicationsuggests there is little evidence that the year ofpublication was related to the outcome reported.In other words, commercial considerations maybe the causative factor of asymmetry (Figure 24).Hydrocolloid dressings were amongst the firstmodern dressings to be intensively marketed <strong>and</strong>companies would be unlikely to publish researchwith negative results. A similar publication bias41

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!